SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,590,489 | +37.2% | 54,368 | +29.6% | 0.02% | 0.0% |
| Q2 2023 | $4,802,511 | -38.5% | 41,936 | -25.9% | 0.02% | -85.5% |
| Q1 2023 | $7,805,175 | -6.6% | 56,629 | -12.2% | 0.12% | -23.0% |
| Q4 2022 | $8,353,893 | +190.7% | 64,469 | +148.0% | 0.15% | +176.4% |
| Q3 2022 | $2,874,000 | -31.1% | 26,000 | -51.3% | 0.06% | -50.5% |
| Q1 2022 | $4,169,000 | +111.6% | 53,361 | +144.0% | 0.11% | +82.0% |
| Q4 2021 | $1,970,000 | +401.3% | 21,873 | +415.0% | 0.06% | +454.5% |
| Q3 2021 | $393,000 | -53.3% | 4,247 | -62.4% | 0.01% | -77.6% |
| Q1 2021 | $841,000 | -77.1% | 11,282 | -60.4% | 0.05% | -79.4% |
| Q4 2019 | $3,678,000 | +232.2% | 28,500 | +93.9% | 0.24% | +260.6% |
| Q3 2019 | $1,107,000 | -34.4% | 14,700 | +32.3% | 0.07% | -64.3% |
| Q2 2019 | $1,688,000 | – | 11,111 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |